All Releases
|
|---|
 |
Inverness Completes Acquisition of Cholestech
09-12-07
|
8.2 KB
|
| |
WALTHAM, Mass., Sept 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today the successful completion of its acquisition of Cholestech Corporation (Nasdaq: CTEC). Inverness ...
|
|
|
New Cholestech LDX System Test Makes Statin Management Easier
08-28-07
|
9.9 KB
|
| |
HAYWARD, Calif., Aug 28, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC), a leading provider of alternate site health management solutions for chronic diseases, announces the launch of its new Lipid Profile*ALT test cassette. This new, CLIA waived cassette combines a lipid profile with ALT (alanine amino...
|
|
|
Cholestech Announces Financial Results for First Quarter of Fiscal 2008
08-02-07
|
13.6 KB
|
| |
HAYWARD, Calif., Aug 02, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC) today reported its earnings for the first quarter of fiscal 2008 ended June 29, 2007.
-- Revenue was up 8% over the prior year quarter to $18.1 million
-- Gross margin was 64.8% for the quarter, compared to 66.6% for ...
|
|
|
Cholestech Announces Fiscal 2008 First Quarter Earnings Release Date and Conference Call
07-24-07
|
9.7 KB
|
| |
HAYWARD, Calif., July 24, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC) today announced that it will release its fiscal 2008 first quarter financial results prior to the market's opening on Thursday, August 2, 2007. The Company will also host a conference call and webcast available to all interested pa...
|
|
|
FDA Grants CLIA Waived Status to Cholestech for New Combined Test Panel
07-12-07
|
9.2 KB
|
| |
HAYWARD, Calif., July 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC), a leading provider of alternate site health management solutions for chronic disease, announces that the FDA has granted CLIA waived status to the Company's newest test panel, Lipid Profile ALT. The new test panel, designed for us...
|
|
|
Inverness Medical Innovations Agrees to Acquire Cholestech Corporation
06-04-07
|
12.4 KB
|
| |
WALTHAM, Mass. and HAYWARD, Calif., June 4, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Inverness Medical Innovations, Inc. (Amex: IMA) and Cholestech Corporation (Nasdaq: CTEC) today announced that they have entered into a definitive merger agreement pursuant to which Inverness will acquire Cholestech Corporation, in a stock for stock m...
|
|
|
Onsite Health Diagnostics and Cholestech Corporation Bring Preventive Health Screenings Directly to Employers
05-30-07
|
11.2 KB
|
| |
HAYWARD, Calif., May 30, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC), a leading provider of alternate site health management solutions for chronic disease, announced today that it has teamed up with Onsite Health Diagnostics, one of the largest providers of comprehensive, on-site, corporate health sc...
|
|
|
New AHA Guidelines Increase the Number of Children and Adolescents Recommended for Cholesterol Screening
05-09-07
|
11.1 KB
|
| |
HAYWARD, Calif., May 9, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- One-third to nearly one-half of all children and adolescents should be tested for cholesterol levels, according to new guidelines recently published by The American Heart Association in Circulation. According to the AHA, the physicians who care for these at-risk youth fa...
|
|
|
Cholestech Announces Fourth Quarter of Fiscal 2007 Results
05-09-07
|
16.9 KB
|
| |
HAYWARD, Calif., May 9, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC) today announced revenue of $18 million for the fourth quarter ended March 30, 2007 compared to revenue of $17.6 million in the prior year fourth quarter. Revenue for the fiscal year ended March 30, 2007 was $69.5 million compared to ...
|
|
|
Cholestech Announces Fiscal 2007 Fourth Quarter and Year-End Earnings Release Date and Conference Call
04-30-07
|
9.7 KB
|
| |
HAYWARD, Calif., April 30, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC) today announced that it will release its fiscal 2007 fourth quarter and year-end financial results prior to the market's opening on Wednesday, May 9, 2007. The Company will also host a conference call and webcast available to all ...
|
|
|
Cholestech to Present at the Sidoti & Company Emerging Growth Institutional Investor Conference
03-22-07
|
6.8 KB
|
| |
HAYWARD, Calif., March 22, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC), a leading manufacturer of point of care testing devices, today announced that Ken Miller, Vice President of Sales and Marketing will present at the Sidoti & Company Emerging Growth Institutional Investor Conference on Tuesday, Ma...
|
|
|
Cholestech to Present at the 8th Annual B. Riley Las Vegas Investor Conference
03-07-07
|
7.1 KB
|
| |
HAYWARD, Calif., March 7, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC), a leading manufacturer of point of care testing devices, today announced that Jack Glenn, CFO and Ken Miller, Vice President of Sales and Marketing will present at the B. Riley 8th Annual Las Vegas Investor Conference on Wednesday...
|
|
|
Cholestech System Benefits Stanford University School of Medicine Study
02-26-07
|
10.7 KB
|
| |
HAYWARD, Calif., Feb 26, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- The Stanford Prevention Research Center of the Stanford University School of Medicine and the San Mateo Medical Center in San Mateo, CA, have confirmed the benefits of alternate site cholesterol and glucose screening, counseling and patient health care management in imp...
|
|
|
Cholestech to Present at the 19th Annual Roth Capital Partners Investor Conference
02-14-07
|
7.1 KB
|
| |
HAYWARD, Calif., Feb 14, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC), a leading manufacturer of point of care testing devices, today announced that Warren E. Pinckert II, President and CEO, and Jack Glenn, CFO, will present at the Roth Capital Partners' 19th Annual OC Investor Conference on Tuesday, ...
|
|
|
Cholestech Corporation Launches New Dermatology Kit for In-office Cholesterol, Liver and Pregnancy Screening
02-08-07
|
10.6 KB
|
| |
HAYWARD, Calif., Feb 08, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC), the nation's leading provider of health management solutions for chronic disease, announces the launch of its new Dermatology Kit for use in monitoring the key health indicators of Accutane patients -- lipid and liver functions.
...
|
|
|
Cholestech Announces Financial Results for Third Quarter of Fiscal 2007
01-31-07
|
14.9 KB
|
| |
HAYWARD, Calif., Jan 31, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC) today announced revenue of $17.5 million and net income of $2.3 million for its third quarter ended December 29, 2006 compared to revenue of $16.2 million and net income of $321,000 in the prior year third quarter.
* Gross...
|
|
|
Cholestech Announces Fiscal 2007 Third Quarter Earnings Release Date and Conference Call
01-16-07
|
9.0 KB
|
| |
HAYWARD, Calif., Jan 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC) today announced that it will release its fiscal 2007 third quarter financial results prior to the market's opening on Wednesday, January 31, 2007. The Company will also host a conference call and webcast available to all interested ...
|
|
|
Medicare Promotes the Value of One-on-One Time for Doctors and Patients
12-06-06
|
10.0 KB
|
| |
HAYWARD, Calif., Dec 06, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- The increased rate Medicare is set to pay physicians in 2007 for simple conversations with their patients legitimizes what doctors and patients have long known: an ounce of prevention is worth a pound of cure. Many doctors are taking the opportunity to heart by incorpor...
|
|
|
Trans Fat Raises Cardiac Health Concerns
11-14-06
|
9.3 KB
|
| |
HAYWARD, Calif., Nov 14, 2006 /PRNewswire via COMTEX News Network/ -- The possible ban on trans fat for New York City restaurants has sparked a renewed interest in heart health and cholesterol. The concern is valid; studies show a strong correlation between trans fat and LDL, or "bad" cholesterol. According to the American Heart Association, a high...
|
|
|
Cholestech Corporation and Life Line Screening Team Up to Bring Stroke, Heart Disease and Diabetes Screenings Directly to Consumers
11-08-06
|
10.6 KB
|
| |
HAYWARD, Calif., Nov 08, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Cholestech Corporation (Nasdaq: CTEC), a leading provider of point-of-care health management solutions for chronic disease, and Life Line Screening, America's leading provider of mobile preventive health screenings, have teamed up to bring cholesterol, glucose and c-rea...
|
|
|
